Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef

被引:37
作者
Akari, H [1 ]
Uchiyama, T [1 ]
Fukumori, T [1 ]
Iida, S [1 ]
Koyama, AH [1 ]
Adachi, A [1 ]
机构
[1] Univ Tokushima, Sch Med, Dept Virol, Tokushima 7708503, Japan
关键词
D O I
10.1099/0022-1317-80-11-2945
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The functions of Vif and Nef in human immunodeficiency virus type 1 (HIV-1) infection have some similarities: Vif- and Nef-dependent enhancement of HIV-1 replication is cell type-specific, and defective mutations in these genes result in restricted proviral DNA synthesis in infected cells. It has recently been shown that pseudotyping HIV-1 by the envelope glycoprotein of vesicular stomatitis virus (VSV-G) targets HIV-1 entry to an endocytic pathway and suppresses the requirement of Nef for virus infectivity. In this study, we examined whether VSV-G pseudotyping suppresses the requirement of Vif for HIV-1 infectivity. It was found that pseudotyping HIV-1 by VSV-G did not compensate for the Vif function. Together with the findings that Vif does not influence virus binding/entry and virion incorporation of Env, it is concluded that Vif enhances HIV-1 infectivity at the post-entry step(s) independently of the Env function by a different mechanism to that of Nef.
引用
收藏
页码:2945 / 2949
页数:5
相关论文
共 40 条
  • [21] THE HUMAN IMMUNODEFICIENCY VIRUS-1 NEF GENE-PRODUCT - A POSITIVE FACTOR FOR VIRAL-INFECTION AND REPLICATION IN PRIMARY LYMPHOCYTES AND MACROPHAGES
    MILLER, MD
    WARMERDAM, MT
    GASTON, I
    GREENE, WC
    FEINBERG, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) : 101 - 113
  • [22] CONSTRUCTION AND USE OF A HUMAN-IMMUNODEFICIENCY-VIRUS VECTOR FOR ANALYSIS OF VIRUS INFECTIVITY
    PAGE, KA
    LANDAU, NR
    LITTMAN, DR
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (11) : 5270 - 5276
  • [23] DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS
    POPOVIC, M
    SARNGADHARAN, MG
    READ, E
    GALLO, RC
    [J]. SCIENCE, 1984, 224 (4648) : 497 - 500
  • [24] COMPARATIVE ANALYSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HIV-2 VIF MUTANTS
    REDDY, TR
    KRAUS, G
    YAMADA, O
    LOONEY, DJ
    SUHASINI, M
    WONGSTAAL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3549 - 3553
  • [25] Efficient HIV-1 replication can occur in the absence of the viral matrix protein
    Reil, H
    Bukovsky, AA
    Gelderblom, HR
    Göttlinger, HG
    [J]. EMBO JOURNAL, 1998, 17 (09) : 2699 - 2708
  • [26] CELL-DEPENDENT REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF PROTEIN FOR MATURATION OF VIRUS-PARTICLES
    SAKAI, H
    SHIBATA, R
    SAKURAGI, J
    SAKURAGI, S
    KAWAMURA, M
    ADACHI, A
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (03) : 1663 - 1666
  • [27] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF INCREASES THE EFFICIENCY OF REVERSE TRANSCRIPTION IN THE INFECTED CELL
    SCHWARTZ, O
    MARECHAL, V
    DANOS, O
    HEARD, JM
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (07) : 4053 - 4059
  • [28] SCHWEDLER UV, 1993, J VIROL, V67, P4945
  • [29] GENERATION OF A CHIMERIC HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUS INFECTIOUS TO MONKEY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    SHIBATA, R
    KAWAMURA, M
    SAKAI, H
    HAYAMI, M
    ISHIMOTO, A
    ADACHI, A
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (07) : 3514 - 3520
  • [30] Evidence for a newly discovered cellular anti-HIV-1 phenotype
    Simon, JHM
    Gaddis, NC
    Fouchier, RAM
    Malim, MH
    [J]. NATURE MEDICINE, 1998, 4 (12) : 1397 - 1400